Wells Fargo Initiates Coverage On Bio-Rad Laboratories with Overweight Rating, Announces $430 Price Target

Wells Fargo analyst Dan Leonard initiates coverage on Bio-Rad Laboratories (NYSE:BIO) with a Overweight rating and a $430 price target.

Benzinga · 01/08/2020 13:51

Wells Fargo analyst Dan Leonard initiates coverage on Bio-Rad Laboratories (NYSE:BIO) with a Overweight rating and a $430 price target.